高雄市生物科技發展協會|http://www.khba.org.tw
會員登入
記住帳號 自動登入
會員名錄
各式辦法
下載專區
留言板
您目前的位置:首頁 / 活動與新訊
Gut microbiome plays a role in immune response to mRNA COVID vaccines
活動日期:2024.01.23
2024.01.23  

Gut microbiome plays a role in immune response to mRNA COVID vaccines

https://reurl.cc/v0anlk

Jan 4 2024Karolinska Institutet

Researchers from Karolinska Institutet in Sweden have discovered that the gut microbiome can influence how well people respond to mRNA COVID vaccines. The study, published in the journal npj Biofilms and Microbiomes, suggests that certain bacteria in the gut can enhance the immune response to the vaccine, whereas other bacteria may weaken it.

The gut microbiome is the collection of microorganisms that live in our digestive tract. It plays an important role in many aspects of our health, such as digestion, metabolism, and immunity. The researchers wanted to find out if the gut microbiome also affects the response to mRNA COVID vaccines. To do this, the researchers collected stool samples from 68 people living with HIV and 75 healthy individuals before their first mRNA COVID vaccine dose.

The researchers analysed the microbiome composition using a technique called 16S rRNA sequencing, which identifies the types and relative abundance of bacteria in the samples. They also measured the levels of antibodies and immune cells that were produced after the vaccination.

We correlated the microbial composition with immune responses and patient characteristics. This comprehensive analysis included age, gender, body mass index and clinical factors for people living with HIV, aiming to understand the complex relationship between gut microbes and vaccine efficacy."

Piotr Nowak, principal investigator, senior physician and associate professor at Karolinska Institutet's Department of Medicine, Huddinge

The results showed that the initial makeup of the gut microbiome could predict the immune response to the vaccine in both groups. They found that a less diverse gut microbiome was associated with a stronger vaccine response, marked by higher levels of spike protein antibodies and spike specific CD4 T-cells. These are key components of the immune system that help to neutralize the virus and prevent severe infection.

The researchers also identified specific bacteria that were linked with better or worse vaccine responses. For example, they found that Lactobacillus, Bacteroides, and Lachnospira were associated with higher antibody and immune cell levels, while Cloacibacillus was associated with lower antibody levels. They also found that Bifidobacterium and Faecalibacterium were microbial markers of individuals with higher antibody levels.

Omics eBook Compilation of the top interviews, articles, and news in the last year.Download the latest edition

According to the researchers, the study highlights the significant role of the gut microbiome in the effectiveness of mRNA COVID vaccines. The findings could lead to developing microbiota-focused treatments to enhance vaccine responses, especially in groups that may have weaker responses, such as the elderly or immunocompromised individuals. The potential strategies could include changing the diet or taking probiotics to improve the gut microbiome and immunity, the researchers suggest.

The study was conducted in collaboration with the Karolinska University Hospital, and SciLifeLab National Genomics Infrastructure in Stockholm, Sweden. The research was funded by Region Stockholm, the Swedish Research Council, and Physicians Against AIDS.

Source:

Karolinska Institutet

Journal reference:

Ray, S., et al. (2023). Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV. npj Biofilms and Microbiomesdoi.org/10.1038/s41522-023-00461-w.

共有314筆資料 頁數: 第12頁(共16頁)
編號 標題 新增日期
1 經策會資訊:中華電信第二梯次報名 2013.04.30
2 兩篇Science文章:遏制腫瘤生長的新武器—20130408 2013.04.09
3 Bones Get in Her Eyes 2013.01.23
4 第68届API CHINA 2012 中國國際原料藥展(秋​季.. 2012.05.17
5 謹訂於10月18日(四)舉辦「2012臺北生技獎醫療器材得獎廠商參訪.. 2012.10.15
6 癌症與細菌之間關係研究的最新報導 2012.09.19
7 7月26日「2012臺北生技大師圓桌論壇」 2012.07.04
8 2012台北生技獎徵選開跑 2012.05.29
9 自由電子報 -〈醫學研究〉興大發現酵素FAK 調控癌細胞轉移的關鍵 2012.05.25
10 2012台北生技獎暨生技研發補助說明會 2012.04.23
11 治禿福音 日本幹細胞育毛成功 (自由電子報) 2012.04.19
12 自由電子報 - 萬用癌症疫苗 最快6年內問世 2012.04.09
13 企業結盟- 明文彥&益全&豐禾 2012.04.03
14 2008 RFID應用推動研討會 2008.11.17
15 國科會生物處業務說明暨座談會 2008.10.01
16 藥事論壇講座(第三十屆)『新興製藥技術產品及藥品不純物業界說.. 2008.09.26
17 2008東南亞市場-泰國、馬來西亞拓商 2008.09.18
18 生技研發服務平台發表會 2008.09.17
19 2008國際抗癌藥物技術媒介會 2008.09.16
20 2008台北生技獎頒獎典禮暨成果發表會 2008.09.11
上一頁  1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16  下一頁
版權所有©2006 高雄市生物科技發展協會 所有文字、資料禁止轉用
地址:高雄市中正一路120號14樓之3 TEL:(07)591-9569 / FAX:(07)591-9018 / e-mail: khba.tw@gmail.com
累積進站人數:3132056